Sector revisions Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.24 USD | -4.01% |
|
-2.76% | +48.21% |
| 30/06 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark | CI |
| 30/06 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 6 | |||||||
| 23 | |||||||
| 22 | |||||||
| 19 | |||||||
| 27 | |||||||
| 24 | |||||||
| - | 18 | ||||||
| 12 | |||||||
| 14 | |||||||
| 23 | |||||||
| 6 | |||||||
| 16 | |||||||
| 15 | |||||||
| 12 | |||||||
| 16 | |||||||
| 12 | |||||||
| 21 | |||||||
| 16 | |||||||
| 18 | |||||||
| 13 | |||||||
| Average | 17 | |||||||
| Weighted average by Cap. | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
